Skip to main content
OpenTrials

Clinical trial condition

Rhabdoid Tumor

Explore clinical trials studying Rhabdoid Tumor. Study availability and eligibility vary by location and protocol.

91 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Rhabdoid Tumor trial results

Completed

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors

NCT00003141

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +26 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center Los Angeles, California, United States
  • Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States
View all 71 locations
View Trial Details
Completed

Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer

NCT00002485

Conditions
Adnexal Diseases, Astrocytoma, Brain Diseases, +96 more
Locations
  • University of California Davis Medical Center Sacramento, California, United States
  • Shands Hospital and Clinics, University of Florida Gainesville, Florida, United States
  • Sylvester Cancer Center, University of Miami Miami, Florida, United States
  • CCOP - Florida Pediatric Tampa, Florida, United States
View all 31 locations
View Trial Details
Completed

Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors

NCT01076530

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +67 more
Locations
  • Childrens Memorial Hospital Chicago, Illinois, United States
  • C S Mott Children's Hospital Ann Arbor, Michigan, United States
  • University of Minnesota Medical Center-Fairview Minneapolis, Minnesota, United States
  • Oregon Health and Science University Portland, Oregon, United States
View Trial Details
Completed

Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor

NCT00047177

Conditions
Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, Familial ependymoma, +15 more
Locations
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Children's Memorial Hospital - Chicago Chicago, Illinois, United States
  • Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors

NCT00015899

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +31 more
Locations
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Duke Comprehensive Cancer Center Durham, North Carolina, United States
View Trial Details
Active, Not Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)

NCT03155620

Conditions
Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, +99 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
View all 172 locations
View Trial Details
Active, Not Recruiting

Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial

NCT04284774

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine Gland Neoplasms, Endocrine System Diseases, +102 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
View all 172 locations
View Trial Details

Related conditions